AEM vs GROY

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

GROY presents a contradictory profile characterized by a very weak Piotroski F-Score of 2/9, indicating poor fundamental health, yet offset by a pristine balance sheet with zero debt and high liquidity. While revenue growth is robust at 34.20% and gross margins are exceptional (92.97%), the company struggles with net profitability and an extremely high Price-to-Sales ratio of 52.63. The stock has seen massive 1-year gains (+135.8%), but current technical trends are bearish and the lack of consistent earnings makes it a speculative play on gold royalties rather than a value investment.